Stocks Industrials EYPT
NASDAQ · IndustrialsEyePoint, Inc. (EYPT)
EyePoint, Inc. brought in $2.8M of revenue over the twelve months to June 30, 2026, down 94.6% from a year earlier. It posted a net loss of $306.6M. In fiscal 2025 capital spending exceeded operating cash flow by $243.4M. At June 30, 2026 it held $110.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about EyePoint, Inc.
- Net worth
- EyePoint, Inc. has a market value (market cap) of $34.8M at the latest share price, and shareholders' equity of $166.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $31.4M (-27.5% year on year), with a net loss of $232M. Over the 12 months to June 30, 2026: revenue $2.8M, net loss $306.6M.
- Cash flow
- In fiscal 2025 operations used $240.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- EyePoint, Inc.'s next report is expected around December 24, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What EyePoint, Inc. does
EyePoint, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on NASDAQ under the ticker EYPT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $31.4M | -$232M | -$3.17 | -$243.4M |
| 2024 | $43.3M | -$130.9M | -$2.32 | -$130.3M |
| 2023 | $46M | -$70.8M | -$1.82 | -$1.6M |
| 2022 | $41.4M | -$102.3M | -$2.74 | -$67.2M |
| 2021 | $36.9M | -$58.4M | -$2.03 | -$50.3M |
| 2020 | $34.4M | -$45.4M | -$3.54 | -$14.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where EYPT ranks in Industrials
Latest SEC filings
What EyePoint, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- October 27, 2026Passive stake (5% or more) SCHEDULE 13G
- October 19, 2026
- October 19, 2026Other event 8-K
- September 10, 2026Other event 8-K
- September 8, 2026Passive stake (5% or more) SCHEDULE 13G
- August 17, 2026Other event 8-K
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- August 5, 2026
Insider trades
What the people running EyePoint, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $52.3K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 20, 2026 | Elston GeorgeChief Financial Officer | Other changeindirect | 5,000 | - |
| August 20, 2026 | Elston GeorgeChief Financial Officer | Other change | 5,000 | - |
| August 20, 2026 | Elston GeorgeChief Financial Officer | Gave as a gift | 64,953 | - |
| August 20, 2026 | Elston GeorgeChief Financial Officer | Gave as a giftindirect | 64,953 | - |
| August 18, 2026 | Zaderej Karen L.Director | Bought | 10,600 | $52.3K |
| July 10, 2026 | Duker Jay S.President and CEO, Director | Exercised options | 16,667 | - |
| July 10, 2026 | Duker Jay S.President and CEO, Director | Shares withheld for tax | 8,059 | $118.6K |
| June 30, 2026 | Ribeiro RamiroChief Medical Officer | Exercised options | 2,437 | $20.1K |
Who owns EYPT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| JANUS HENDERSON GROUP Ltd.13G, passive | 10.9% | September 8, 2026 |
| Tang Capital Management, LLC13G, passive with 5 related filers | 9.6% | October 27, 2026 |
| Cormorant Asset Management, LP13G, passive with 1 related filers | 8.35% | August 14, 2026 |
| Adage Capital Management, L.P.13G, passive with 2 related filers | 5.71% | August 12, 2026 |
| Commodore Capital LP13G, passive with 3 related filers | 5.1% | June 3, 2026 |
| Vanguard Capital Management13G, passive | 5.03% | July 31, 2026 |
| Essex Woodlands Fund IX-GP, L.P.13D, may seek influence with 8 related filers | 5% | December 8, 2023 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 189 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Montanova Capital, LLC | 8,296,375 | 0 |
| BlackRock, Inc. | 7,463,197 | +285,860 |
| Cormorant Asset Management, LP | 7,000,000 | -1,265,000 |
| Federated Hermes, Inc. | 5,681,052 | +11,463 |
| Adage Capital Partners GP, L.L.C. | 4,827,792 | +1,527,792 |
| Franklin Resources Inc | 4,807,078 | -241,520 |
| Commodore Capital LP | 4,600,000 | +1,775,000 |
| Jupiter Topco LLC | 3,770,381 | new |
| Vanguard Capital Management LLC | 3,630,252 | +70,683 |
| Paradigm Biocapital Advisors LP | 2,890,397 | -252,040 |
| State Street Corp | 2,357,545 | +260,343 |
| Geode Capital Management, LLC | 2,062,390 | +78,725 |
| Aberdeen Group plc | 2,008,802 | +270,424 |
| Citadel Advisors LLC | 1,977,610 | +71,735 |
| Balyasny Asset Management L.P. | 1,812,358 | +373,621 |
| Parkman Healthcare Partners LLC | 1,288,163 | -66,637 |
| Eventide Asset Management, LLC | 1,245,583 | 0 |
| Two Sigma Investments, LP | 1,181,143 | +750,828 |
| Essex Woodlands Management, Inc. | 1,084,857 | 0 |
| Orbimed Advisors LLC | 1,069,147 | 0 |
Insiders
5 insiders reported holding 8,892,941 shares in total, about $3.6M at the last price.
| Holder | Shares |
|---|---|
| Cormorant Asset Management, LPFormer 10% Owner | 8,265,0008,265,000 held indirectly |
| Lurker NancyDirector | 294,346 |
| Duker Jay S.President and CEO, Director | 187,025177,431 held indirectly |
| Elston GeorgeChief Financial Officer | 97,47064,953 held indirectly |
| Zaderej Karen L.Director | 49,100 |
Questions about EYPT
What does EyePoint, Inc. do?
EyePoint, Inc. is a company in the Industrials sector, listed on NASDAQ as EYPT. Its shares trade on NASDAQ under the ticker EYPT.
What is EyePoint, Inc.'s net worth?
EyePoint, Inc. has a market value (market cap) of $34.8M at the latest share price, and shareholders' equity of $166.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is EyePoint, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $306.6M on revenue of $2.8M.
How much revenue does EyePoint, Inc. make?
Over the twelve months to June 30, 2026 EyePoint, Inc. reported revenue of $2.8M. That is 94.6% less than a year earlier.
When did EyePoint, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from October 30, 2026.
When is EyePoint, Inc.'s next earnings report?
EyePoint, Inc.'s next report is expected around December 24, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare EYPT with
Follow EYPT
Get an email when EyePoint, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values EyePoint, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.